Skip to main content

Table 3 Allergic rhino-conjunctivitis-specific recommendations from ARIA/EAACI (from: Bousquet et al. 2020) [37]

From: Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model

With the current knowledge, in patients with COVID-19 infection, intra-nasal corticosteroid (including spray) can be continued in allergic rhinitis at the recommended dose
Stopping local intra-nasal corticosteroid is not advised. Suppression of the immune system has not been proven and more sneezing after stopping means more spreading of the Coronavirus
These recommendations are conditional since there is a paucity of data and they should be revised regularly with new knowledge